| 1. | | Recruiting | Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ... |
| 2. | | Recruiting | Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer
Conditions: adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ... |
| 3. | | Recruiting | Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer
Conditions: adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ... |
| 4. | | Recruiting | Combination Chemotherapy and Thalidomide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes
Conditions: adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ... |
| 5. | | Recruiting | VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ... |
| 6. | | Recruiting | CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ... |
| 7. | | Recruiting | Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia
Conditions: adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ... |
| 8. | | Recruiting | Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome
Conditions: Acute Myeloid Leukemia; adult acute monoblastic and acute monocytic leukemia; atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; ... |
| 9. | | Recruiting | Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome
Conditions: adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ... |
| 10. | | Recruiting | Bone Marrow Transplantation Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer
Conditions: Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; atypical chronic myeloid leukemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia; ... |
| 11. | | Recruiting | 3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; Chronic Myelogenous Leukemia; secondary acute myeloid leukemia |
| 12. | | Recruiting | VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia
Conditions: adult acute myeloid leukemia; atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; ... |
| 13. | | Recruiting | Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
Conditions: adult acute myeloid leukemia; atypical chronic myeloid leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes; ... |
| 14. | | Recruiting | Radiolabeled Monoclonal Antibody Therapy Combined With Total-body Irradiation, Allogeneic Peripheral Stem Cell Transplantation, and Immunosuppression Therapy in Treating Older Patients Who Have Advanced Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
Conditions: adult acute myeloid leukemia; atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; Graft Versus Host Disease; ... |
| 15. | | Recruiting | Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer
Conditions: adult acute myeloid leukemia; atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; ... |
| 16. | | Recruiting | R115777 in Treating Patients With Myeloproliferative Disorders
Conditions: atypical chronic myeloid leukemia; Chronic Myelogenous Leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease |
| 17. | | Recruiting | Donor Stem Cell Transplantation With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome
Conditions: atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; juvenile myelomonocytic leukemia; myelodysplastic and myeloproliferative disease; ... |
| 18. | | Recruiting | Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia
Conditions: adult acute myeloid leukemia; childhood acute myeloid leukemia; secondary acute myeloid leukemia |
| 19. | | Recruiting | OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ... |
| 20. | | Not yet recruiting | Biological Therapy in Treating Patients With Advanced Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; ... |
| 21. | | Recruiting | Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
Conditions: relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; accelerated phase chronic myelogenous leukemia; ... |
| 22. | | Recruiting | Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia; adult acute monoblastic and acute monocytic leukemia; atypical chronic myeloid leukemia; childhood acute monocytic leukemia; ... |
| 23. | | Recruiting | Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia
Conditions: blastic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; ... |
| 24. | | Recruiting | PKC412 With or Without Itraconazole in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Conditions: adult acute myeloid leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes |
| 25. | | Recruiting | Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome
Conditions: adult acute myeloid leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes |
| 26. | | Recruiting | Tipifarnib in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome in Complete Remission
Conditions: adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes |
| 27. | | Recruiting | Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia
Conditions: accelerated phase chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia; ... |
| 28. | | Recruiting | Chemotherapy, Biological Therapy, and/or Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
Conditions: chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ... |
| 29. | | Recruiting | Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia
Conditions: relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ... |
| 30. | | Recruiting | Dose-Determining Study of R115777 for Childhood Leukemia
Conditions: Acute Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Acute Nonlymphocytic Leukemia; Acute Myelomonocytic Leukemia; ... |
| 31. | | Recruiting | Bortezomib in Treating Patients With Chronic Myelogenous Leukemia
Conditions: relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; accelerated phase chronic myelogenous leukemia; ... |
| 32. | | Recruiting | Cyclophosphamide and Filgrastim Followed By Peripheral Stem Cell Transplantation in Treating Patients With Chronic or Accelerated Phase Myelogenous Leukemia
Conditions: chronic phase chronic myelogenous leukemia; accelerated phase chronic myelogenous leukemia; ... |
| 33. | | Recruiting | PTK 787 and Gleevec in Patients with AML, AMM, and CML-BP
Conditions: Acute Myelogenous Leukemia; Agnogenic Myeloid Metaplasia; Chronic Myelogenous Leukemia |
| 34. | | Recruiting | Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
Conditions: untreated adult acute myeloid leukemia; secondary acute myeloid leukemia; adult acute myeloid leukemia with t(8;21)(q22;q22); ... |
| 35. | | Not yet recruiting | Adoptive Immunotherapy and Interleukin-2 in Treating Patients With Recurrent Accelerated or Blast Phase Chronic Myelogenous Leukemia After Undergoing Allogeneic Stem Cell Transplantation
Conditions: accelerated phase chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia; relapsing chronic myelogenous leukemia; ... |
| 36. | | Recruiting | Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; Chronic Myelogenous Leukemia |
| 37. | | Recruiting | FR901228 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Conditions: adult acute myeloid leukemia; secondary acute myeloid leukemia |
| 38. | | Recruiting | Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Acute Leukemia
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia |
| 39. | | Recruiting | Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia
Conditions: adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia |
| 40. | | Recruiting | Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia
Conditions: adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia |
| 41. | | Recruiting | Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia |
| 42. | | Recruiting | Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia
Conditions: adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia |
| 43. | | Recruiting | Daunorubicin and Cytarabine With or Without Zosuquidar Trihydrochloride in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia
Conditions: adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; Myelodysplastic Syndromes; secondary acute myeloid leukemia |
| 44. | | Recruiting | Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission
Conditions: adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia |
| 45. | | Recruiting | Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia
Conditions: adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia |
| 46. | | Recruiting | Daunorubicin and Cytarabine With or Without Oblimersen in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: adult acute myeloid leukemia; secondary acute myeloid leukemia |
| 47. | | Recruiting | Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
Conditions: adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia |
| 48. | | Recruiting | Anti-Thymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplantation for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; Graft Versus Host Disease; secondary acute myeloid leukemia |
| 49. | | Not yet recruiting | Reduced-Intensity Regimen Before Donor Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndromes
Conditions: atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes |
| 50. | | Recruiting | Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome
Conditions: atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes |
